Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bradanicline in Refractory Chronic Cough
NCT03622216Phase 2Completed
- Sponsor
- Attenua
- Start
- Nov 2018
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bradanicline in chronic cough, sponsored by Attenua. Started Nov 2018; status: completed.
02
Drugs
bradanicline
03
Conditions
chronic cough
Beyond the preview
Go deeper on NCT03622216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03622216.